Skip to content
GenoLensGenoLens

ANKRD17

Chr 4q13.3

ankyrin repeat domain 17

Aliases:
GTAR, KIAA0697, FLJ22206, NY-BR-16, MASK2
MANE:
ENST00000358602.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • Chopra-Amiel-Gordon syndrome

    0.78
  • neurodegenerative disease

    0.55
  • hereditary disease

    0.52
  • neurodevelopmental disorder

    0.37
  • complex neurodevelopmental disorder

    0.37
  • syndromic complex neurodevelopmental disorder

    0.37
  • atrial fibrillation

    0.34
  • lip and oral cavity carcinoma

    0.34
  • placenta praevia

    0.32
  • Intellectual disability

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Ankyrin repeat domain-containing protein 17

Could play pivotal roles in cell cycle and DNA regulation (PubMed:19150984). Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways (PubMed:22328336). Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too (PubMed:23711367). Target of enterovirus 71 which is the major etiological agent of HFMD (hand, foot and mouth disease) (PubMed:17276651). Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.